Best Practice & Research Clinical Anaesthesiology
Volume 24, Issue 1 , Pages 85-93 , March 2010

F. XIII in perioperative coagulation management

  • Wolfgang Korte, MD, PhD (Associate Professor of Medicine)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: + 41 71 4943973; Fax: +41 71 4943900.

References 

  1. Lorand L. Fibrinoligase: the fibrin-stabilizing factor system of blood plasma. Annals of the New York Academy of Sciences. 1972;202:6–30
  2. Duckert F, Jung E, Shmerling DH. A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency. Thrombosis et Diathesis Haemorrhagica. 1960;5:179–186
  3. Schroeder V, Meili E, Cung T, et al. Characterisation of six novel A-subunit mutations leading to congenital factor XIII deficiency and molecular analysis of the first diagnosed patient with this rare bleeding disorder. Thrombosis and haemostasis. 2006;95:77–84
  4. Nakamura S, Kato A, Sakata Y, Aoki N. Bleeding tendency caused by IgG inhibitor to factor XIII, treated successfully by cyclophosphamide. British Journal of Haematology. 1988;68:313–319
  5. Lorand L, Velasco PT, Rinne JR, et al. Autoimmune antibody (IgG Kansas) against the fibrin stabilizing factor (factor XIII) system. Proceedings of the National Academy of Sciences of the United States of America. 1988;85:232–236
  6. Ariens RA, Philippou H, Nagaswami C, et al. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood. 2000;96:988–995
  7. Loewy AG. Some thoughts on the state in nature, biosynthetic origin, and function of factor XIII. Annals of the New York Academy of Sciences. 1972;202:41–58
  8. Inbal A, Lubetsky A, Krapp T, et al. Impaired wound healing in factor XIII deficient mice. Thrombosis and Haemostasis. 2005;94:432–437
  9. Siebenlist KR, Meh DA, Mosesson MW. Plasma factor XIII binds specifically to fibrinogen molecules containing gamma chains. Biochemistry. 1996;35:10448–10453
  10. Siebenlist KR, Meh DA, Mosesson MW. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin. Thrombosis and Haemostasis. 2001;86:1221–1228
  11. Mosesson MW, Siebenlist KR, Meh DA. The structure and biological features of fibrinogen and fibrin. Annals of the New York Academy of Sciences. 2001;936:11–30
  12. Weisberg LJ, Shiu DT, Greenberg CS, et al. Localization of the gene for coagulation factor XIII a-chain to chromosome 6 and identification of sites of synthesis. The Journal of Clinical Investigation. 1987;79:649–652
  13. Ichinose A, Hendrickson LE, Fujikawa K, et al. Amino acid sequence of the a subunit of human factor XIII. Biochemistry. 1986;25:6900–6906
  14. Ichinose A, McMullen BA, Fujikawa K, et al. Amino acid sequence of the b subunit of human factor XIII, a protein composed of ten repetitive segments. Biochemistry. 1986;25:4633–4638
  15. Kangsadalampai S, Board PG. The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity. Blood. 1998;92:2766–2770
  16. Muszbek L, Adany R, Mikkola H. Novel aspects of blood coagulation factor XIII.I. Structure, distribution, activation, and function. Critical Reviews in Clinical Laboratory Sciences. 1996;33:357–421
  17. Adany R, Muszbek L. Immunohistochemical detection of factor XIII subunit a in histiocytes of human uterus. Histochemistry. 1989;91:169–174
  18. Fear JD, Jackson P, Gray C, et al. Localisation of factor XIII in human tissues using an immunoperoxidase technique. Journal of Clinical Pathology. 1984;37:560–563
  19. Mosesson MW. Fibrinogen and fibrin polymerization: appraisal of the binding events that accompany fibrin generation and fibrin clot assembly. Blood Coagulation & Fibrinolysis. 1997;8:257–267
  20. Casadio R, Polverini E, Mariani P, et al. The structural basis for the regulation of tissue transglutaminase by calcium ions. European journal of Biochemistry/FEBS. 1999;262:672–679
  21. Fox BA, Yee VC, Pedersen LC, et al. Identification of the calcium binding site and a novel ytterbium site in blood coagulation factor XIII by x-ray crystallography. The Journal of Biological Chemistry. 1999;274:4917–4923
  22. Tamaki T, Aoki N. Cross-linking of alpha 2-plasmin inhibitor to fibrin catalyzed by activated fibrin-stabilizing factor. The Journal of Biological Chemistry. 1982;257:14767–14772
  23. Mosesson MW, Siebenlist KR, Hernandez I, et al. Evidence that alpha2-antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation. Journal of Thrombosis And Haemostasis. 2008;6:1565–1570
  24. Fickenscher K, Aab A, Stuber W. A photometric assay for blood coagulation factor XIII. Thrombosis And Haemostasis. 1991;65:535–540
  25. Wilmer M, Rudin K, Kolde H, et al. Evaluation of a sensitive colorimetric fxiii incorporation assay. effects of fxiii val34leu, plasma fibrinogen concentration and congenital fxiii deficiency. Thrombosis Research. 2001;102:81–91
  26. Dempfle CE, Harenberg J, Hochreuter K, et al. Microtiter assay for measurement of factor XIII activity in plasma. The Journal of Laboratory and Clinical Medicine. 1992;119:522–528
  27. Nishida Y, Ikematsu S, Fukutake K, et al. A new rapid and simple assay for factor XIII activity using dansylcadaverine incorporation and gel filtration. Thrombosis Research. 1984;36:123–131
  28. Ivaskevicius V, Windyga J, Baran B, et al. Phenotype-genotype correlation in eight Polish patients with inherited Factor XIII deficiency: identification of three novel mutations. Haemophilia. 2007;13:649–657
  29. Ivaskevicius V, Seitz R, Kohler HP, et al. International registry on factor XIII deficiency: a basis formed mostly on European data. Thrombosis And Haemostasis. 2007;97:914–921
  30. Fadoo Z, Saleem AF. Factor XIII deficiency in children–clinical presentation and outcome. Journal of the College of Physicians and Surgeons--Pakistan. 2008;18:565–568
  31. Schroeder V, Durrer D, Meili E, et al. Congenital factor XIII deficiency in Switzerland: from the worldwide first case in 1960 to its molecular characterisation in 2005. Swiss Medical Weekly. 2007;137:272–278
  32. Bhattacharya M, Biswas A, Ahmed RP, et al. Clinico-hematologic profile of factor XIII-deficient patients. Clinical and Applied Thrombosis/Hemostasis. 2005;11:475–480
  33. Padmanabhan LD, Mhaskar R, Mhaskar A, et al. Factor XIII deficiency: a rare cause of repeated abortions. Singapore Medical Journal. 2004;45:186–187
  34. Asahina T, Kobayashi T, Takeuchi K, et al. Congenital blood coagulation factor XIII deficiency and successful deliveries: a review of the literature. Obstetrical & Gynecological Survey. 2007;62:255–260
  35. Egbring R, Kroniger A, Seitz R. Factor XIII deficiency: pathogenic mechanisms and clinical significance. Seminars in Thrombosis and Hemostasis. 1996;22:419–425
  36. Meili EO. [Clinical course and management of severe congenital factor XIII deficiency], Hamostaseologie. 2002;22:48–52
  37. Kitchens CS, Newcomb TF. Factor XIII. Medicine (Baltimore). 1979;58:413–429
  38. Gerlach R, Raabe A, Zimmermann M, et al. Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures. Surgical Neurology. 2000;54:260–264discussion 4–5
  39. Gerlach R, Tolle F, Raabe A, et al. Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study. Stroke. 2002;33:1618–1623
  40. Godje O, Haushofer M, Lamm P, et al. The effect of factor XIII on bleeding in coronary surgery. Thorac Cardiovasc Surg. 1998;46:263–267
  41. Godje O, Gallmeier U, Schelian M, et al. Coagulation Factor XIII Reduces Postoperative Bleeding After Coronary Surgery with Extracorporeal Circulation. Thorac Cardiovasc Surg. 2006;54:26–33
  42. Wettstein P, Haeberli A, Stutz M, et al. Decreased factor XIII availability for thrombin and early loss of clot firmness in patients with unexplained intra-operative bleeding. Anesthesia and Analgesia. 2004;99:1564–1569table of contents
  43. Korte WC, Szadkowski C, Gahler A, et al. Factor XIII substitution in surgical cancer patients at high risk for intra-operative bleeding. Anesthesiology. 2009;110:239–245
  44. Korte W, Hinnen C, Degiacomi P, et al. XIII deficiency in the surgical intensive care unit is more frequent than a relevant fibrinogen deficiency. Haemostaseologie. 2007;27:A61
  45. Hoffman MA. cell-based model of coagulation and the role of factor VIIa. Blood Reviews. 2003;17(Suppl. 1):S1–S5
  46. Lorand L. Factor XIII and the clotting of fibrinogen: from basic research to medicine. Journal of Thrombosis and Haemostasis. 2005;3:1337–1348
  47. Siebenlist KR, Mosesson MW. Factors affecting gamma-chain multimer formation in cross-linked fibrin. Biochemistry. 1992;31:936–941
  48. Mosesson MW. Fibrinogen gamma chain functions. Journal of Thrombosis and Haemostasis. 2003;1:231–238
  49. Ichinose A. Physiopathology and regulation of factor XIII. Thrombosis and Haemostasis. 2001;86:57–65
  50. Hornyak TJ, Shafer JA. Role of calcium ion in the generation of factor XIII activity. Biochemistry. 1991;30:6175–6182
  51. Brummel KE, Butenas S, Mann KG. An integrated study of fibrinogen during blood coagulation. The Journal of Biological Chemistry. 1999;274:22862–22870
  52. Paye M, Nusgens B, Lapiere CM. Factor XIII of blood coagulation decreases the susceptibility of collagen precursors to proteolysis. Biochim Biophys Acta. 1991;1073:437–441
  53. Barry EL, Mosher DF. Factor XIIIa-mediated cross-linking of fibronectin in fibroblast cell layers. Cross-linking of cellular and plasma fibronectin and of amino-terminal fibronectin fragments. The Journal of Biological Chemistry. 1989;264:4179–4185
  54. Brown LF, Lanir N, McDonagh J, et al. Fibroblast migration in fibrin gel matrices. The American Journal of Pathology. 1993;142:273–283
  55. Blome M, Isgro F, Kiessling AH, et al. Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. Thrombosis and Haemostasis. 2005;93:1101–1107
  56. Korte W, Truttmann B, Heim C, et al. Preoperative values of molecular coagulation markers identify patients at low risk for intra-operative haemostatic disorders and excessive blood loss. Clinical Chemistry and Laboratory Medicine. 1998;36:235–240
  57. Wettstein P, Haeberli A, Stutz M, et al. Decreased Factor XIII Availability for Thrombin and Early Loss of Clot Firmness in Patients with Unexplained Intra-operative Bleeding. Anesthesia and Analgesia. 2004;99:1564–1569
  58. Korte W, Gabi K, Rohner M, et al. Preoperative fibrin monomer measurement allows risk stratification for high intra-operative blood loss in elective surgery. Thrombosis and Haemostasis. 2005;94:211–215
  59. Noll T, Wozniak G, McCarson K, et al. Effect of factor XIII on endothelial barrier function. The Journal of Experimental Medicine. 1999;189:1373–1382
  60. Birnbaum J, Hein OV, Luhrs C, et al. Effects of coagulation factor XIII on intestinal functional capillary density, leukocyte adherence and mesenteric plasma extravasation in experimental endotoxemia. Critical Care. 2006;10:R29
  61. Marzano AV, Federici AB, Gasparini G, et al. Coagulation factor XIII, endothelial damage and systemic sclerosis. European Journal of Dermatology. 2000;10:14–17
  62. Wozniak G, Noll T, Akinturk H, et al. Factor XIII prevents development of myocardial edema in children undergoing surgery for congenital heart disease. Annals of the New York Academy of Sciences. 2001;936:617–620
  63. Nahrendorf M, Hu K, Frantz S, et al. Factor XIII deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarction. Circulation. 2006;113:1196–1202
  64. Wozniak G, Noll T, Bott U, et al. Factor XIII: experimental and clinical results in diabetic foot ulcer, Zentralbl Chir. 1999;124(Suppl. 1):73–77
  65. Dardik R, Leor J, Skutelsky E, et al. Evaluation of the pro-angiogenic effect of factor XIII in heterotopic mouse heart allografts and FXIII-deficient mice. Thrombosis and Haemostasis. 2006;95:546–550
  66. Cario E, Goebell H, Dignass AU. Factor XIII modulates intestinal epithelial wound healing in vitro. Scandinavian Journal of Gastroenterology. 1999;34:485–490
  67. Zaets SB, Xu DZ, Lu Q, et al. Recombinant factor XIII diminishes multiple organ dysfunction in rats caused by gut ischemia-reperfusion injury. Shock. 31. Augusta: Ga; 2009;621–6

PII: S1521-6896(09)00075-5

doi: 10.1016/j.bpa.2009.09.011

Best Practice & Research Clinical Anaesthesiology
Volume 24, Issue 1 , Pages 85-93 , March 2010

Article Tools

* Image Usage & Resolution